Efficacy of a Pseudomonas aeruginosa Serogroup O9 Vaccine
D. A. Moustafa, A. DiGiandomenico, V. Raghuram, M. Schulman, J. Scarff, M. R. Davis, J. J. Varga, C. Dean, J. B. Goldberg
This study develops a vaccine against Pseudomonas aeruginosa serogroup O9 using an attenuated Salmonella strain expressing the O9 LPS, showing it induces protective immunity in mice.
bioRxiv · Jul 13, 2023 · PreprintMicrobiology